Cargando…

Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric Cancer

BACKGROUND: Glycosylation involved in various biological function, aberrant glycosylation plays an important role in cancer development and progression. Glycosyltransferase 8 domain containing 1 (GLT8D1) and GLT8D2, as members of the glycosyltransferase family proteins, are associated with transfera...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Huimei, Huang, Ke, Lin, Yimin, Gong, Hang, Ma, Xueni, Zhang, Dekui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242987/
https://www.ncbi.nlm.nih.gov/pubmed/37277853
http://dx.doi.org/10.1186/s12920-023-01559-y
_version_ 1785054334728273920
author Xu, Huimei
Huang, Ke
Lin, Yimin
Gong, Hang
Ma, Xueni
Zhang, Dekui
author_facet Xu, Huimei
Huang, Ke
Lin, Yimin
Gong, Hang
Ma, Xueni
Zhang, Dekui
author_sort Xu, Huimei
collection PubMed
description BACKGROUND: Glycosylation involved in various biological function, aberrant glycosylation plays an important role in cancer development and progression. Glycosyltransferase 8 domain containing 1 (GLT8D1) and GLT8D2, as members of the glycosyltransferase family proteins, are associated with transferase activity. However, the association between GLT8D1/2 and gastric cancer (GC) remains unclear. We aimed to investigate the potential prognostic value and oncogenic role of GLT8D1/2 in GC. METHODS: The relationship between GLT8D1/2 and GC was evaluated through comprehensive bioinformatics approaches. A series of factors like gene expression patterns, Kaplan-Meier survival analyses, Cox regression analyses, prognostic nomogram, calibration curves, ROC curves, function enrichment analyses, tumor immunity association, genetic alterations, and DNA methylation were included. Data and statistical analyses were performed using R software (v3.6.3). RESULTS: Both GLT8D1 and GLT8D2 expression were significantly upregulated in GC tissues(n = 414) compared with normal tissues(n = 210), and high expression of GLT8D1/2 was remarkably correlated with poor prognosis for GC patients. Cox regression analyses implied that GLT8D1/2 could act as independent prognostic factors in GC. Furthermore, gene function analyses indicated that multiple signaling pathways involving tumor oncogenesis and development enriched, such as mTOR, cell cycle, MAPK, Notch, Hedgehog, FGF, and PI3K-Akt signaling pathways. Moreover, GLT8D1/2 was significantly associated with immune cell infiltration, immune checkpoint genes, and immune regulators TMB/MSI. CONCLUSION: GLT8D1/2 may serve as potential prognostic markers of poor prognosis in GC correlated with tumor immunity. The study provided an insight into identifying potential biomarkers and targets for prognosis, immunotherapy response, and therapy in GC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12920-023-01559-y.
format Online
Article
Text
id pubmed-10242987
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102429872023-06-07 Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric Cancer Xu, Huimei Huang, Ke Lin, Yimin Gong, Hang Ma, Xueni Zhang, Dekui BMC Med Genomics Research BACKGROUND: Glycosylation involved in various biological function, aberrant glycosylation plays an important role in cancer development and progression. Glycosyltransferase 8 domain containing 1 (GLT8D1) and GLT8D2, as members of the glycosyltransferase family proteins, are associated with transferase activity. However, the association between GLT8D1/2 and gastric cancer (GC) remains unclear. We aimed to investigate the potential prognostic value and oncogenic role of GLT8D1/2 in GC. METHODS: The relationship between GLT8D1/2 and GC was evaluated through comprehensive bioinformatics approaches. A series of factors like gene expression patterns, Kaplan-Meier survival analyses, Cox regression analyses, prognostic nomogram, calibration curves, ROC curves, function enrichment analyses, tumor immunity association, genetic alterations, and DNA methylation were included. Data and statistical analyses were performed using R software (v3.6.3). RESULTS: Both GLT8D1 and GLT8D2 expression were significantly upregulated in GC tissues(n = 414) compared with normal tissues(n = 210), and high expression of GLT8D1/2 was remarkably correlated with poor prognosis for GC patients. Cox regression analyses implied that GLT8D1/2 could act as independent prognostic factors in GC. Furthermore, gene function analyses indicated that multiple signaling pathways involving tumor oncogenesis and development enriched, such as mTOR, cell cycle, MAPK, Notch, Hedgehog, FGF, and PI3K-Akt signaling pathways. Moreover, GLT8D1/2 was significantly associated with immune cell infiltration, immune checkpoint genes, and immune regulators TMB/MSI. CONCLUSION: GLT8D1/2 may serve as potential prognostic markers of poor prognosis in GC correlated with tumor immunity. The study provided an insight into identifying potential biomarkers and targets for prognosis, immunotherapy response, and therapy in GC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12920-023-01559-y. BioMed Central 2023-06-05 /pmc/articles/PMC10242987/ /pubmed/37277853 http://dx.doi.org/10.1186/s12920-023-01559-y Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Xu, Huimei
Huang, Ke
Lin, Yimin
Gong, Hang
Ma, Xueni
Zhang, Dekui
Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric Cancer
title Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric Cancer
title_full Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric Cancer
title_fullStr Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric Cancer
title_full_unstemmed Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric Cancer
title_short Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric Cancer
title_sort glycosyltransferase glt8d1 and glt8d2 serve as potential prognostic biomarkers correlated with tumor immunity in gastric cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242987/
https://www.ncbi.nlm.nih.gov/pubmed/37277853
http://dx.doi.org/10.1186/s12920-023-01559-y
work_keys_str_mv AT xuhuimei glycosyltransferaseglt8d1andglt8d2serveaspotentialprognosticbiomarkerscorrelatedwithtumorimmunityingastriccancer
AT huangke glycosyltransferaseglt8d1andglt8d2serveaspotentialprognosticbiomarkerscorrelatedwithtumorimmunityingastriccancer
AT linyimin glycosyltransferaseglt8d1andglt8d2serveaspotentialprognosticbiomarkerscorrelatedwithtumorimmunityingastriccancer
AT gonghang glycosyltransferaseglt8d1andglt8d2serveaspotentialprognosticbiomarkerscorrelatedwithtumorimmunityingastriccancer
AT maxueni glycosyltransferaseglt8d1andglt8d2serveaspotentialprognosticbiomarkerscorrelatedwithtumorimmunityingastriccancer
AT zhangdekui glycosyltransferaseglt8d1andglt8d2serveaspotentialprognosticbiomarkerscorrelatedwithtumorimmunityingastriccancer